Innovation in obesity treatments, Alzheimer's detection and medical-device applications is setting the stage for a number of ...

Saluda Medical announced that it appointed Barry Regan as its new president and CEO, effective July 14, 2025. Regan most ...

Avivomed, Inc., a privately held, clinical-stage, medical device company, announced the appointment of Dan Brounstein as its new Chief Executive Officer and Board Member. Brounstein succeeds CEO Steve ...

02.06.2021: Clinical review - Spinal cord stimulation with weak electric current is a neuromodulatory treatment suitable for subgroups of patients with chronic neuropathic pain and certain other pain ...

Researchers at Chalmers University of Technology in Sweden and the University of Auckland in New Zealand have developed a ...

If a person qualifies for spinal cord stimulator therapy, coverage will fall under Medicare Part B. After a person meets their deductible, Part B will pay for 80% of the cost.

Unlike humans, rats have a greater capacity for spontaneous recovery after spinal cord injury, which allowed researchers to compare natural healing with healing supported by electrical stimulation.

Onward Medical announced today that it submitted its ARC-EX system for expanded FDA indication and for CE mark approval.

Spinal cord injury leads to lasting motor and sensory loss, with limited treatment options. Here, the authors show that subdural electric field stimulation delivered across the injury via an ultra ...

Alzheimer's disease (AD) is a debilitating neurodegenerative condition that affects a significant proportion of older people ...

The global Pain Management Devices Market is estimated to be valued at USD 7245.4 million in 2025 and is projected to reach USD 14,786.0 million by 2035, registering a compound annual growth rate ...